Novo Nordisk (NVO) is just such a company, and I recently purchased it for Morningstar StockInvestor's real-money Hare portfolio.

Stock of Novo Nordisk A/S (ADR) (NYSE:NVO) fell -3.51% in last trading session and is closed $ 167.58 with average volume 223,767.00 shares.

Today, Wall Street Reports announced new research reports highlighting St. Jude Medical, Inc. (NYSE:STJ) , Teva Pharmaceutical Industries Ltd.

... Industries Ltd (ADR) (NYSE:TEVA). These stocks are Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY), Pharmacyclics, Inc. (NASDAQ:PCYC), Forest Laboratories, Inc. (NYSE:FRX), Novo Nordisk A/S (ADR) (NYSE:NVO), and Allergan, Inc. (NYSE:AGN).

Novo Nordisk A/S: Federal Circuit Court rules on patent litigation involving Prandin(R) (repaglinide) Join our daily free Newsletter ... B shares arelisted on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on theNew York Stock Exchange (NVO).

Headquartered in Denmark, Novo Nordisk employs approximately 35,000 employees in 75 countries, and markets its products in more than 180 countries.

Novo Nordisk A/S (ADR) (NYSE:NVO) announced the submission of marketing authorization applications for IDegLira, the combination product of insulin degludec (Tresiba), the once-daily new-generation basal insulin analogue, with an ultra-long direction ...

Its market capitalization is about 11 billion US dollars. Novozymes A/S B shares trade as an ADR with ticker (NVZMY.PK). The A common stock is held by Novo A/S, which is owned by the Novo Nordisk Foundation. In addition, Novo A/S owns about 11% of the ...